Login
Companies $LH
$372.46 +$0.00 (0.0%) After hours
LABCORP HOLDINGS INC. logo

LABCORP HOLDINGS INC.

labcorp.com

What Do They Do?

Performs clinical and specialty laboratory tests for physicians, hospitals, health plans and patients, and provides drug-development laboratory services for pharmaceutical, biotechnology and medical-device companies.

How Do They Make Money?

Diagnostic testing generates fees when testing is complete and results are reported; biopharma laboratory services are billed as work is delivered under fixed-price or fee-for-service contracts.

revenue
SegmentShareRevenue
Diagnostics
78%
FY2022: 78%
Biopharma Laboratory Services
22%
FY2022: 23%

Who Are Their Customers?

Physicians and other healthcare providers order diagnostic tests; health plans, government programs, clients and patients pay for them. Pharmaceutical, biotechnology and medical-device companies and CROs buy drug-development laboratory services through Labcorp's global sales organization.

Do Revenues Turn Into Profits?

Yes. It kept 6 cents of every revenue dollar as net income in FY2025 and turned 9 cents into free cash flow.

Operating income, FY2025
10% of revenue
▲ +27% vs FY2024 ($1.1B, 8%)
Net income, FY2025
6% of revenue
▲ +17% vs FY2024 ($746M, 6%)
Free cash flow, FY2025
9% of revenue
▲ +10% vs FY2024 ($1.1B, 8%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +7%
vs $3.6B in Q3 FY2025
Net income
▲ +1%
vs $261.1M in Q3 FY2025
Diagnostics share of revenue vs 77.7% in Q3 FY2025

Flat. Revenue was $14B in FY2025, about the same as the $13.1B of FY2021.

Revenue over time
Diagnostics Biopharma Laboratory Services Covance Drug Development
$20B$10B$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support